Product NDC: | 0019-1317 |
Proprietary Name: | MD-76R |
Non Proprietary Name: | Diatrizoate meglumine and Diatrizoate sodium |
Active Ingredient(s): | 660; 100 mg/mL; mg/mL & nbsp; Diatrizoate meglumine and Diatrizoate sodium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0019-1317 |
Labeler Name: | Mallinckrodt Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019292 |
Marketing Category: | NDA |
Start Marketing Date: | 19890929 |
Package NDC: | 0019-1317-11 |
Package Description: | 12 BOTTLE, GLASS in 1 BOX (0019-1317-11) > 150 mL in 1 BOTTLE, GLASS |
NDC Code | 0019-1317-11 |
Proprietary Name | MD-76R |
Package Description | 12 BOTTLE, GLASS in 1 BOX (0019-1317-11) > 150 mL in 1 BOTTLE, GLASS |
Product NDC | 0019-1317 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Diatrizoate meglumine and Diatrizoate sodium |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19890929 |
Marketing Category Name | NDA |
Labeler Name | Mallinckrodt Inc. |
Substance Name | DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM |
Strength Number | 660; 100 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA],Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |